About Sisu Global Health
Sisu Global Health is a company based in Baltimore (United States) founded in 2014 by Carolyn Yarina, Katherine Kirsch, and Gillian Henker.. Sisu Global Health has raised $2.2 million across 14 funding rounds from investors including Johns Hopkins University, USAID and TEDCO. Sisu Global Health offers products and services including Hemafuse and rEvolve. Sisu Global Health operates in a competitive market with competitors including Haemonetics, VISIE, Haermonics, i-sep and ProCell, among others.
- Headquarter Baltimore, United States
- Founders Carolyn Yarina, Katherine Kirsch, Gillian Henker
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sisu Global Health Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.2 M (USD)
in 14 rounds
-
Latest Funding Round
$3.14 M (USD), Debt – Conventional
Apr 19, 2022
-
Investors
Johns Hopkins University
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sisu Global Health
Sisu Global Health offers a comprehensive portfolio of products and services, including Hemafuse and rEvolve. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Handheld device for salvaging and re-transfusing blood during surgeries.
Additional device related to Hemafuse for blood management applications.
Funding Insights of Sisu Global Health
Sisu Global Health has successfully raised a total of $2.2M across 14 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $3.14 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 14
- Last Round Debt – Conventional — $3.1M
-
First Round
First Round
(01 Dec 2014)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2022 | Amount | Debt – Conventional - Sisu Global Health | Valuation |
investors |
|
| Apr, 2021 | Amount | Debt – Conventional - Sisu Global Health | Valuation |
investors |
|
| Sep, 2018 | Amount | Seed - Sisu Global Health | Valuation | Michbelles |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sisu Global Health
Sisu Global Health has secured backing from 10 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Johns Hopkins University, USAID and TEDCO. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Revolution is recognized as a D.C.-based investment firm.
|
Founded Year | Domain | Location | |
|
Startup accelerator
|
Founded Year | Domain | Location | |
|
Venture capital fund and startup accelerator programs focused on seed and early stage companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sisu Global Health
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sisu Global Health
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sisu Global Health Comparisons
Competitors of Sisu Global Health
Sisu Global Health operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Haemonetics, VISIE, Haermonics, i-sep and ProCell, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Hematology products and solutions are provided for medical applications.
|
|
| domain | founded_year | HQ Location |
Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery
|
|
| domain | founded_year | HQ Location |
Postoperative pericardial drainage and flushing system is developed.
|
|
| domain | founded_year | HQ Location |
Cell salvage solutions for autologous blood transfusion during surgery
|
|
| domain | founded_year | HQ Location |
Develops medical devices for intraoperative blood recovery and conservation.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sisu Global Health
Frequently Asked Questions about Sisu Global Health
When was Sisu Global Health founded?
Sisu Global Health was founded in 2014.
Where is Sisu Global Health located?
Sisu Global Health is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
Who is the current CEO of Sisu Global Health?
Carolyn Yarina is the current CEO of Sisu Global Health. They have also founded this company.
Is Sisu Global Health a funded company?
Sisu Global Health is a funded company, having raised a total of $2.2M across 14 funding rounds to date. The company's 1st funding round was a Seed of $1.2M, raised on Dec 01, 2014.
What does Sisu Global Health do?
Sisu Global Health was founded in 2014 in Baltimore, United States, within the medical devices sector. Intraoperative autotransfusion solutions are offered, including the Hemafuse, a handheld mechanical device used for collecting and transfusing blood from internal hemorrhages in emergencies. Additionally, the Evolve modular centrifuge is provided, enabling blood separation in three minutes to support surgical procedures.
Who are the top competitors of Sisu Global Health?
Sisu Global Health's top competitors include Haemonetics, VISIE and Gate Science.
What products or services does Sisu Global Health offer?
Sisu Global Health offers Hemafuse and rEvolve.
Who are Sisu Global Health's investors?
Sisu Global Health has 10 investors. Key investors include Johns Hopkins University, USAID, TEDCO, Revolution, and Mich Belles.